Finasteride for Hair Loss: How It Works, Effectiveness, and Side Effects

—————————————————————-

Few hair-loss treatments have generated as much research, debate, and quiet daily use as finasteride. A prescription-only medicine marketed as Propecia at 1 mg for hair loss and as Proscar at 5 mg for benign prostatic hyperplasia (BPH), this 5-alpha reductase inhibitor remains one of only a small number of medications with FDA approval for male-pattern hair loss (androgenetic alopecia). Long-term studies show that a large majority of men maintain or partially regrow hair over one to two years of consistent use — but its side-effect profile and the ongoing discussion around persistent symptoms mean it is not a casual, self-directed decision. This article is educational and is not medical advice; finasteride should be prescribed and monitored by a licensed clinician.

Finasteride Is Prescription-Only

Before anything else, an important framing point: finasteride is a prescription medication in the United States. It is not an over-the-counter supplement, and the doses and formulations below are described to help you have an informed conversation with a clinician — not as a plan to follow on your own. A prescriber decides whether finasteride is appropriate for you, which dose to use, and how to monitor it. Do not source finasteride from unregulated online sellers or share someone else’s prescription.

How Finasteride Works

Finasteride blocks type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the androgen most strongly implicated in miniaturizing scalp follicles in genetically susceptible men. By inhibiting the enzyme, finasteride substantially lowers scalp and serum DHT, according to data summarized in the FDA Propecia labeling and on MedlinePlus.

Lower DHT allows miniaturizing follicles to recover toward a more normal hair-shaft diameter and growth duration. Hair that had cycled into thinner, shorter “vellus” hairs can return to thicker terminal hairs in many users. The drug does not shut down testosterone production, although serum testosterone may rise modestly because less is converted to DHT. Finasteride does not revive follicles that have already been lost — it works by stabilizing and partially regrowing what remains, which is why starting earlier tends to preserve more hair.

The same mechanism makes finasteride 5 mg useful for BPH, where it reduces prostate volume by shrinking DHT-driven tissue, as reflected in the AUA BPH guidelines and the Proscar labeling.

Effectiveness: What the Research Shows

The pivotal trials of 1 mg finasteride enrolled men with mild-to-moderate vertex and frontal hair loss. After two years, roughly 83% of men taking finasteride either maintained or increased their hair count, compared with about 28% on placebo. A five-year extension showed continued benefit, with the large majority of treated men maintaining or improving hair density, per data reported in the dermatology literature and reflected in the FDA labeling.

Vertex (crown) response tends to be more visible than frontal hairline response, though both regions can improve. Younger men generally see better outcomes than men starting after age 50. Male-pattern baldness at the temples often responds less dramatically than crown thinning, which is consistent with regional differences in follicle behavior.

Combining finasteride with topical minoxidil generally outperforms either treatment alone in comparative studies, and the American Academy of Dermatology (AAD) describes both as first-line options a dermatologist may recommend for pattern hair loss. Whether to combine them, and how, is a decision for your clinician.

Dosing and Formulations (Prescriber-Directed)

For androgenetic alopecia, the FDA-approved dose is 1 mg once daily, taken with or without food. Some clinicians prescribe finasteride in other ways off-label — for example, using a portion of a 5 mg tablet, or lower-frequency or topical regimens — but any such approach should be chosen and supervised by your prescriber rather than improvised at home, because dose consistency and safety monitoring matter.

Topical finasteride solutions and lower-dose or every-other-day oral regimens have emerged as options that a clinician may consider for men sensitive to side effects; a 2022 randomized trial in JAMA Dermatology found a topical formulation comparable to oral 1 mg for hair-count change over 24 weeks, with less systemic DHT suppression. Importantly, there is currently no FDA-approved topical finasteride product in the US — topical versions are compounded, and in April 2025 the FDA issued an alert about adverse events reported with compounded topical finasteride (including erectile dysfunction, decreased libido, anxiety, depression, suicidal ideation, brain fog, and insomnia), some persisting after stopping. If you consider a compounded product, discuss the risks and the lack of FDA evaluation with your clinician first.

Visible results typically appear around month 4 to month 6, and the benefit is only maintained with continued use. Some men notice a transient increase in shedding in the first few months as follicles enter a new growth phase. Stopping the medication leads to gradual loss of any gained hair over roughly 6 to 12 months as DHT rebounds.

Safety and Side Effects

Not for use around pregnancy — a critical warning

Finasteride can cause abnormalities of the external genitalia in a developing male fetus. For that reason it must not be used by anyone who is pregnant or who may become pregnant, and women who are or may be pregnant should not handle crushed or broken tablets, because the drug can be absorbed. Intact, coated tablets are designed to prevent contact with the active ingredient during normal handling, but damaged tablets are a real exposure risk. If there is any chance of pregnancy exposure, contact a clinician.

Sexual side effects

Sexual side effects are the most discussed risk. In the original 1 mg trials, decreased libido, erectile dysfunction, and ejaculation disorders were each reported by roughly 1-2% of men — a small amount higher than placebo. These effects usually appear early and, for most men, improve while continuing the drug or resolve after stopping.

Persistent symptoms (“post-finasteride syndrome”)

Some men report sexual, mood, or cognitive symptoms that persist after discontinuing finasteride — a pattern often referred to as “post-finasteride syndrome” (PFS). This remains an actively debated area: the prevalence, mechanism, and reversibility are not fully established, and researchers disagree about causation. Regulators have taken the reports seriously — the FDA has updated the Propecia labeling over the years to note reports of persistent sexual dysfunction, and both US and European labeling now reference mood changes. Anyone weighing finasteride should be told about this uncertain but real concern and should feel free to raise it with their prescriber.

Mood and other effects

The product labeling notes depression and reports of suicidal ideation, and advises stopping the drug and seeking medical advice if depressed mood or suicidal thoughts occur. Other documented effects include reduced semen volume, breast tenderness or enlargement (gynecomastia), and, uncommonly, breast changes that should be evaluated. If you experience new or worsening depression or any thoughts of self-harm, stop and contact a clinician right away; in the US you can call or text 988 (the Suicide & Crisis Lifeline) at any time.

Effect on PSA and prostate cancer screening

Finasteride lowers prostate-specific antigen (PSA) by approximately 50%. This matters for prostate cancer screening: a “normal-looking” PSA on finasteride may actually be relatively elevated, so tell any clinician who measures your PSA that you take finasteride — they can interpret or adjust the value accordingly. The FDA and the USPSTF have also noted a nuanced association between 5-alpha reductase inhibitors and the detection of high-grade prostate cancer in screening trials, even though overall prostate cancer incidence was reduced — a risk-benefit conversation worth having with a urologist, particularly for older men.

Who It May Be Right For

Finasteride is most often considered for men with early-to-moderate androgenetic alopecia who want to slow progression and modestly regrow hair. Because of the fetal risk described above, it is generally not used in women of reproductive age; some dermatologists prescribe it off-label for certain postmenopausal women, but that is an individualized clinical decision.

Men with a history of depression, sexual dysfunction, or fertility concerns may want to discuss the trade-offs and alternatives — such as topical minoxidil, low-dose oral minoxidil, or surgical restoration — with a dermatologist. Men taking finasteride 5 mg for other medical conditions such as BPH should not add a separate hair-loss dose without medical guidance, because a single prescription may already cover both concerns. The right choice depends on your goals, health history, and a prescriber’s judgment.

Cost and Availability

Generic finasteride 1 mg is widely available and inexpensive. With discount programs such as GoodRx, a 30-day supply often runs roughly $5 to $20 cash, though prices vary by pharmacy and change over time. Branded Propecia can cost substantially more per month without insurance. Telehealth platforms frequently bundle the medication into monthly subscriptions — but even through telehealth, finasteride requires a clinician’s prescription, and you should still receive the same safety counseling.

Insurance coverage for hair loss is uncommon because it is often classified as cosmetic; finasteride 5 mg for BPH is more broadly covered. Compounded topical formulations cost more through specialty pharmacies and, as noted above, are not FDA-approved. Considering a broader hair-restoration plan? See our hair transplant guide for surgical options that can complement medical therapy under a clinician’s care.

Frequently Asked Questions

How long do I need to take finasteride?

Benefit depends on continued use. Stopping generally leads to gradual reversal of any gains over the following 6 to 12 months. Many men take finasteride long-term, but that is a decision to revisit periodically with your prescriber, weighing benefits and any side effects.

Can finasteride cause permanent sexual side effects?

Most sexual side effects improve while continuing or after stopping the drug. A subset of men report persistent symptoms after discontinuation (“post-finasteride syndrome”). The true incidence is uncertain and the topic is debated, but the possibility is real and worth discussing before starting. Report any persistent symptoms to your clinician.

Does finasteride affect muscle gains or testosterone?

Total testosterone may rise modestly on finasteride because less is converted to DHT. Controlled studies have not consistently shown a meaningful decline in muscle mass or strength. Some men perceive subjective changes; if you have concerns, discuss them with your clinician rather than adjusting the dose yourself.

Is topical finasteride safer than oral?

Topical formulations reduce systemic DHT suppression and may carry fewer sexual side effects, though high-quality long-term data remain limited, no topical version is FDA-approved, and the FDA has flagged adverse events reported with compounded products. Whether a topical option makes sense for you is a conversation to have with a dermatologist.

The Bottom Line

Finasteride works for the majority of men who take it consistently, with strong long-term efficacy data and generally modest cost. The trade-offs are a small but real risk of sexual or mood side effects, a still-debated possibility of persistent symptoms after stopping, an absolute contraindication around pregnancy, and an effect on PSA that your clinicians need to know about. For early-stage hair loss the risk-benefit balance is favorable for many men — but this is a prescription medicine, and the decision belongs in an informed conversation with a dermatologist or a licensed telehealth clinician, not a quick, self-directed checkout.

Sources

• FDA — Propecia and Proscar prescribing information (via DailyMed / Drugs@FDA)
• FDA — Drug Safety Communications on 5-alpha reductase inhibitors and the April 2025 alert on compounded topical finasteride
• American Academy of Dermatology (AAD) — Hair loss: treatment options
• MedlinePlus — Finasteride drug information
• U.S. Preventive Services Task Force — Prostate Cancer: Screening